Medication that helps reduce a person's risk of developing cardiovascular and kidney disease is a cost-effective option to treat Australia's entire population of people with type 2 diabetes, a new study has found.
Dec 1, 2022
0
45
Researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, presented new evidence that drugs originally developed to treat type 2 diabetes may benefit a wide range of patients ...
Aug 29, 2022
0
7
Tagrisso (osimertinib) received approval as an adjuvant treatment for patients with non-small cell lung cancer with epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations, the U.S. Food and Drug ...
Dec 23, 2020
0
5
Getting diagnosed with Alzheimer's disease or another kind of dementia is never pleasant—but a new study shows that when and how someone's cognitive issues come to light can also make a big difference in their health care ...
May 31, 2022
0
8
Among people older than age 65 who were assessed using a short physical function test, having lower physical function was independently associated with a greater risk of developing heart attack, heart failure and stroke, ...
Aug 31, 2022
0
47
In a new study out of University of California San Diego School of Medicine, researchers found a drug used for heart failure improves symptoms associated with postural orthostatic tachycardia syndrome, otherwise known as ...
Feb 15, 2021
0
79
Two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease. ...
Sep 28, 2020
0
11
Canagliflozin, a medication used to treat type 2 diabetes, was found to greatly improve symptoms and quality of life within 3 months for people with heart failure due to either reduced or preserved cardiac function, even ...
Nov 15, 2021
0
4
A new study published in the Journal of the American Medical Association led by researchers from the University of Alabama at Birmingham Marnix E. Heersink School of Medicine found that being a carrier of a genetic variation ...
Apr 14, 2022
0
8
New research at Cleveland Clinic expands the link between what we eat and how the gut microbiome impacts our susceptibility to develop different diseases—in this case, how a specific gut microbe-generated byproduct is linked ...
Dec 16, 2022
0
103
